Brief: Starpharma Holdings Says Signed An Expanded DEP Research Agreement With Genentech
27/06/2022 02:27
June 27 (Reuters) - Starpharma Holdings Ltd SPL.AX :
* SIGNED AN EXPANDED DEP RESEARCH AGREEMENT WITH GENENTECH
Source text for Eikon: ID:nASX4TcLqc
Further company coverage: SPL.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Starpharma Holdings
See all newsBrief: Starpharma Increases Stake In Petalion To 66% Securing Majority Ownership
Brief: Starpharma Seeks Trading Halt
Brief: Starpharma Holdings Appoints Russell Basser As Chair
Brief: Starpharma Says Fully Underwritten Entitlement Offer To Raise A$32 MLN
Australia's Starpharma slumps to 1-1/2-month low on discounted fund raising